ICU Medical Gets FDA Clearance for Infusion Pump-Software Combo
By Dean Seal
ICU Medical has received clearance from the U.S. Food and Drug Administration for its Plum Duo infusion pump with LifeShield infusion safety software.
The San Clemente, Calif.-based company said Tuesday that with the clearance, the Plum Duo pump and LifeShield software will be available to U.S. customers by early 2024.
The pump is the latest addition to the company's portfolio of infusion devices and features a large touch screen, highly intuitive user interface and two channels for delivering up to four compatible IV medications.
The LifeShield software is a cloud-based software suite providing tools for comprehensive drug library management.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
August 29, 2023 08:30 ET (12:30 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom